Existing studies on the pathophysiological mechanisms of SF3B1 mutations in MDS have focused on impaired erythropoiesis, iron metabolism disorders, hyperinflammatory features, and R-loop accumulation, which constitute the significant clinical features of MDS. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.